Dr. Olga Molchanova-Cook
Dr. Olga Molchanova-Cook is a nuclear radiologist and oncologist helping expand access to advanced molecular imaging and radiopharmaceutical therapy for patients in Southern New Mexico and the surrounding region.
Role
Treating Nuclear Radiologist, United Theranostics of New Mexico
Board Certifications
American Board of Radiology, American Board of Nuclear Medicine, and Certification Board of Nuclear Cardiology
Clinical Focus
Molecular imaging, oncology imaging, nuclear medicine, radiopharmaceutical therapy, and rural cancer care access
Affiliations
American Board of Radiology, American Board of Nuclear Medicine, Certification Board of Nuclear Cardiology, SNMMI Southwestern Chapter, and American College of Radiology
Overview
Dr. Olga Molchanova-Cook, MD, PhD, is a nuclear radiologist and oncologist based in Las Cruces, New Mexico. At United Theranostics of New Mexico, she helps bring advanced molecular imaging and radiopharmaceutical therapy closer to patients across the American Southwest.
Her clinical work emphasizes state-of-the-art cancer care, multidisciplinary treatment planning, and expanded access to advanced theranostic services for rural and underserved communities.
Locations
Education & Training
Dr. Molchanova-Cook earned her medical degree from the University of New Mexico School of Medicine. She completed residency training at the University of New Mexico Health Sciences Center, with training in diagnostic radiology and nuclear medicine.
That foundation in imaging and nuclear medicine shaped her clinical focus on molecular diagnostics, oncology imaging, and radiopharmaceutical therapies.
Clinical Focus
Dr. Molchanova-Cook focuses on molecular imaging, oncology imaging, nuclear medicine, and radiopharmaceutical therapy. Her work supports patients who may otherwise need to travel long distances for specialized cancer imaging and treatment.
At United Theranostics of New Mexico, she participates in multidisciplinary tumor boards and collaborates with oncology care teams to support comprehensive treatment planning for cancer patients.
Leadership & Appointments
At United Theranostics of New Mexico, Dr. Molchanova-Cook helps lead the delivery of advanced molecular diagnostic techniques and radiopharmaceutical therapies in Southern New Mexico.
She has also served in leadership with the Southwestern Chapter of the Society of Nuclear Medicine and Molecular Imaging, reflecting her commitment to professional education, regional access, and the continued development of nuclear medicine care.
Research & Publications
Dr. Molchanova-Cook has contributed to peer-reviewed publications in nuclear medicine, oncology imaging, neuroimaging, and radiopharmaceutical therapy. Her published work includes topics such as osmotic demyelination syndrome, FDG PET/CT for infection detection, and radiopharmaceutical pharmacokinetics in prostate cancer.
Her scholarly work reflects a commitment to improving diagnostic accuracy, treatment planning, and patient outcomes through imaging and nuclear medicine.
Professional Affiliations
Dr. Molchanova-Cook is certified by the American Board of Radiology, the American Board of Nuclear Medicine, and the Certification Board of Nuclear Cardiology.
Her professional involvement includes leadership with the SNMMI Southwestern Chapter and committee contributions with organizations such as the American College of Radiology and SNMMI.
Honors & Recognition
Dr. Molchanova-Cook is recognized for helping expand access to advanced molecular imaging and radiopharmaceutical therapy in Southern New Mexico. Her clinical leadership supports the growth of specialized cancer care in a region where patients have historically had fewer local options.
Her participation in regional education, tumor boards, and United Theranostics of New Mexico’s growth reflects a sustained commitment to patient access, physician collaboration, and community-based cancer care.
Contact
Dr. Molchanova-Cook sees patients through United Theranostics – Las Cruces.
Connect With United Theranostics
For patient, provider, or clinical trial questions, contact United Theranostics directly.